Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Eric J. Zhao, Sujaatha Narayanan, Florian Kuchenbauer, Stephen Nantel, Thomas Nevill, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Hannah Cherniawsky, Judith Rodrigo, Kevin Song, Cynthia Toze, Jennifer White, Claudie Roy, Aly Karsan, Ryan Stubbins, David Sanford

Blood (2025) 146 (Supplement 1): 5178.

https://doi.org/10.1182/blood-2025-5178

Published: 2025

Journal Articles

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Blood (2025) 146 (Supplement 1): 2815.

https://doi.org/10.1182/blood-2025-2815

Published: 2025

Journal Articles

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Luciana Melo Garcia, Tzu-Fei Wang, Michael Kennah, Abdullah Alanazi, Sarah Mckeague, John Kuruvilla, Inna Gong, Naomi Marali Xiao, Christopher Lemieux, Camille Sylvestre, Amaris Balitsky, Isabelle Fleury, Mathias Castonguay, Robert Puckrin, Hannah Cherniawsky, Amani Ahmed, Mahmoud Elsawy, Maggie McGuire, Miriam Kimpton

Blood (2025) 146 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2025-4496

Published: 2025

Journal Articles

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Blood (2025) 146 (Supplement 1): 6212.

https://doi.org/10.1182/blood-2025-6212

Published: 2025

Journal Articles

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Nicholas Chornenki, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Judith Rodrigo, Claudie Roy, Kevin Song, Cynthia Toze, Jennifer White, David Sanford, Ryan Stubbins

Blood (2025) 146 (Supplement 1): 5222.

https://doi.org/10.1182/blood-2025-5222

Published: 2025

Journal Articles

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Bo Wan, Curtis Hughesman, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Hannah Cherniawsky, Judith Rodrigo, Aly Karsan, Sean Young, Kevin Song, Ryan Stubbins, Cynthia Toze, Jennifer White, Claudie Roy, David Sanford

Blood (2025) 146 (Supplement 1): 1738.

https://doi.org/10.1182/blood-2025-1738

Published: 2025

Journal Articles

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

Satarupa Mohapatra, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Gagan Kalia, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Deepesh Lad

Blood (2024) 144 (Supplement 1): 7910.

https://doi.org/10.1182/blood-2024-206266

Published: 2024

Journal Articles

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Blood (2024) 144 (Supplement 1): 7649.

https://doi.org/10.1182/blood-2024-193967

Published: 2024

Journal Articles

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Neelan Sriranjan, Shanee Chung, Hannah Cherniawsky, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7113.

https://doi.org/10.1182/blood-2024-211092

Published: 2024

Journal Articles

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Blood (2024) 144 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2024-209687

Published: 2024

Journal Articles

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Amani Ahmed, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7417.

https://doi.org/10.1182/blood-2024-206077

Published: 2024

Journal Articles

Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1 st , 2 nd or 3 rd Line Therapy: Real-World Results from the National Myeloma Canada Research Network (MCRN) Database

Donna E Reece, MD, Esther Masih-Khan, PhD, Eshetu G Atenafu, MSc, P.Stat, Victor Jimenez-Zepeda, MD, Arleigh McCurdy, MD, Kevin Song, MD, Richard Leblanc, MDFRCPC, Michael Sebag, MD PhD, Darrell J White, MD, Hannah Cherniawsky, BSc,MD, Tony Reiman, MD, Julie Stakiw, MD, Martha L Louzada, MDMSc, Rami Kotb, MD, Muhammad Aslam, MD, Engin Gul, BS, MBA, Christopher P Venner, MD

Blood (2019) 134 (Supplement_1): 3173.

https://doi.org/10.1182/blood-2019-125810

Published: 2019

Journal Articles

Lenalidomide Maintenance Does Not Negatively Impact Overall and Progression Free Survival Using Lenalidomide-Based Regimens for Multiple Myeloma in First Relapse

Hannah Cherniawsky, BSc,MD, Zack M. Breckenridge, BSc, Irwindeep Sandhu, MD FRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew R Belch, MD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner, MD FRCPC

Blood (2018) 132 (Supplement 1): 5643.

https://doi.org/10.1182/blood-2018-99-117705

Published: 2018

Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD

Blood (2017) 130 (Supplement 1): 3132.

https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1 st , 2 nd or 3 rd Line Therapy: Real-World Results from the National Myeloma Canada Research Network (MCRN) Database

Lenalidomide Maintenance Does Not Negatively Impact Overall and Progression Free Survival Using Lenalidomide-Based Regimens for Multiple Myeloma in First Relapse

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only